APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cell Therapy CDMO

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cell Therapy CDMO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

4 January 2026195 pages

Choose your research edition.

Industry ResearchCell Therapy CDMO Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Cell Therapy CDMO Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Cell Therapy CDMO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cell Therapy CDMO Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Cell Therapy CDMO Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Cell Therapy CDMO market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Cell Therapy CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cell Therapy CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cell Therapy CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cell Therapy CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cell Therapy CDMO include Catalent, Lonza, Charles River, FUJIFILM Diosynth Biotechnologies, Exothera, Pharmaron, OBiO, AGC Biologics and Cytiva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Cell Therapy CDMO market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cell Therapy CDMO and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cell Therapy CDMO revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Cell Therapy CDMO market size, projected growth trends, production technologies, key applications, and end-use industries.

Cell Therapy CDMO Segment by Company

Catalent

Lonza

Charles River

FUJIFILM Diosynth Biotechnologies

Exothera

Pharmaron

OBiO

AGC Biologics

Cytiva

ThermoGenesis

eXmoor Pharma

Advanced Therapies

Catalent Biologics

Patheon Pharma Services

Sartorius

Genezen

The Discovery Labs

Cell Therapy CDMO Segment by Type

Autologous Cell Therapy CDMO

Allogeneic Cell Therapy CDMO

Viral Vector and Gene Editing CDMO

Cell Therapy CDMO Segment by Application

Commercial

Academic Research

Others

Cell Therapy CDMO Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Therapy CDMO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell Therapy CDMO and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Therapy CDMO.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Cell Therapy CDMO in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cell Therapy CDMO industry.

Chapter 3: Detailed analysis of Cell Therapy CDMO companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell Therapy CDMOrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cell Therapy CDMO Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Autologous Cell Therapy CDMO Table 3. Key Players of Allogeneic Cell Therapy CDMO Table 4. Key Players of Viral Vector and Gene Editing CDMO Table 4. Global Cell Therapy CDMO Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Commercial Table 6. Key Players of Academic Research Table 7. Key Players of Others Table 8. Global Cell Therapy CDMO Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Cell Therapy CDMO Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Cell Therapy CDMO Market Share by Region (2021-2026) Table 11. Global Cell Therapy CDMO Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Cell Therapy CDMO Market Share by Region (2027-2032) Table 13. Cell Therapy CDMO Industry Trends Table 14. Cell Therapy CDMO Industry Drivers Table 15. Cell Therapy CDMO Industry Opportunities and Challenges Table 16. Cell Therapy CDMO Industry Restraints Table 17. Global Cell Therapy CDMO Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Cell Therapy CDMO Revenue Market Share by Company (2021-2026) Table 19. Global Cell Therapy CDMO Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Cell Therapy CDMO Key Company Head Office and Area Served Table 21. Global Cell Therapy CDMO Company, Product Type & Application Table 22. Global Cell Therapy CDMO Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Cell Therapy CDMO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Cell Therapy CDMO Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Cell Therapy CDMO Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Cell Therapy CDMO Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Cell Therapy CDMO Revenue Market Share by Type (2021-2026) Table 29. Global Cell Therapy CDMO Revenue Market Share by Type (2027-2032) Table 30. Global Cell Therapy CDMO Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Cell Therapy CDMO Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Cell Therapy CDMO Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Cell Therapy CDMO Revenue Market Share by Application (2021-2026) Table 34. Global Cell Therapy CDMO Revenue Market Share by Application (2027-2032) Table 35. Catalent Company Information Table 36. Catalent Business Overview Table 37. Catalent Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Catalent Cell Therapy CDMO Product Portfolio Table 39. Catalent Recent Development Table 40. Lonza Company Information Table 41. Lonza Business Overview Table 42. Lonza Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Lonza Cell Therapy CDMO Product Portfolio Table 44. Lonza Recent Development Table 45. Charles River Company Information Table 46. Charles River Business Overview Table 47. Charles River Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Charles River Cell Therapy CDMO Product Portfolio Table 49. Charles River Recent Development Table 50. FUJIFILM Diosynth Biotechnologies Company Information Table 51. FUJIFILM Diosynth Biotechnologies Business Overview Table 52. FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Product Portfolio Table 54. FUJIFILM Diosynth Biotechnologies Recent Development Table 55. Exothera Company Information Table 56. Exothera Business Overview Table 57. Exothera Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Exothera Cell Therapy CDMO Product Portfolio Table 59. Exothera Recent Development Table 60. Pharmaron Company Information Table 61. Pharmaron Business Overview Table 62. Pharmaron Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Pharmaron Cell Therapy CDMO Product Portfolio Table 64. Pharmaron Recent Development Table 65. OBiO Company Information Table 66. OBiO Business Overview Table 67. OBiO Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. OBiO Cell Therapy CDMO Product Portfolio Table 69. OBiO Recent Development Table 70. AGC Biologics Company Information Table 71. AGC Biologics Business Overview Table 72. AGC Biologics Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. AGC Biologics Cell Therapy CDMO Product Portfolio Table 74. AGC Biologics Recent Development Table 75. Cytiva Company Information Table 76. Cytiva Business Overview Table 77. Cytiva Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Cytiva Cell Therapy CDMO Product Portfolio Table 79. Cytiva Recent Development Table 80. ThermoGenesis Company Information Table 81. ThermoGenesis Business Overview Table 82. ThermoGenesis Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. ThermoGenesis Cell Therapy CDMO Product Portfolio Table 84. ThermoGenesis Recent Development Table 85. eXmoor Pharma Company Information Table 86. eXmoor Pharma Business Overview Table 87. eXmoor Pharma Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. eXmoor Pharma Cell Therapy CDMO Product Portfolio Table 89. eXmoor Pharma Recent Development Table 90. Advanced Therapies Company Information Table 91. Advanced Therapies Business Overview Table 92. Advanced Therapies Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Advanced Therapies Cell Therapy CDMO Product Portfolio Table 94. Advanced Therapies Recent Development Table 95. Catalent Biologics Company Information Table 96. Catalent Biologics Business Overview Table 97. Catalent Biologics Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Catalent Biologics Cell Therapy CDMO Product Portfolio Table 99. Catalent Biologics Recent Development Table 100. Patheon Pharma Services Company Information Table 101. Patheon Pharma Services Business Overview Table 102. Patheon Pharma Services Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Patheon Pharma Services Cell Therapy CDMO Product Portfolio Table 104. Patheon Pharma Services Recent Development Table 105. Sartorius Company Information Table 106. Sartorius Business Overview Table 107. Sartorius Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Sartorius Cell Therapy CDMO Product Portfolio Table 109. Sartorius Recent Development Table 110. Genezen Company Information Table 111. Genezen Business Overview Table 112. Genezen Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Genezen Cell Therapy CDMO Product Portfolio Table 114. Genezen Recent Development Table 115. The Discovery Labs Company Information Table 116. The Discovery Labs Business Overview Table 117. The Discovery Labs Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. The Discovery Labs Cell Therapy CDMO Product Portfolio Table 119. The Discovery Labs Recent Development Table 120. North America Cell Therapy CDMO Market Size by Type (2021-2026) & (US$ Million) Table 121. North America Cell Therapy CDMO Market Size by Type (2027-2032) & (US$ Million) Table 122. North America Cell Therapy CDMO Market Size by Application (2021-2026) & (US$ Million) Table 123. North America Cell Therapy CDMO Market Size by Application (2027-2032) & (US$ Million) Table 124. North America Cell Therapy CDMO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. North America Cell Therapy CDMO Market Size by Country (2021-2026) Table 126. North America Cell Therapy CDMO Market Size by Country (2027-2032) Table 127. Europe Cell Therapy CDMO Market Size by Type (2021-2026) & (US$ Million) Table 128. Europe Cell Therapy CDMO Market Size by Type (2027-2032) & (US$ Million) Table 129. Europe Cell Therapy CDMO Market Size by Application (2021-2026) & (US$ Million) Table 130. Europe Cell Therapy CDMO Market Size by Application (2027-2032) & (US$ Million) Table 131. Europe Cell Therapy CDMO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Europe Cell Therapy CDMO Market Size by Country (2021-2026) Table 133. Europe Cell Therapy CDMO Market Size by Country (2027-2032) Table 134. China Cell Therapy CDMO Market Size by Type (2021-2026) & (US$ Million) Table 135. China Cell Therapy CDMO Market Size by Type (2027-2032) & (US$ Million) Table 136. China Cell Therapy CDMO Market Size by Application (2021-2026) & (US$ Million) Table 137. China Cell Therapy CDMO Market Size by Application (2027-2032) & (US$ Million) Table 138. Asia Cell Therapy CDMO Market Size by Type (2021-2026) & (US$ Million) Table 139. Asia Cell Therapy CDMO Market Size by Type (2027-2032) & (US$ Million) Table 140. Asia Cell Therapy CDMO Market Size by Application (2021-2026) & (US$ Million) Table 141. Asia Cell Therapy CDMO Market Size by Application (2027-2032) & (US$ Million) Table 142. Asia Cell Therapy CDMO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Asia Cell Therapy CDMO Market Size by Country (2021-2026) Table 144. Asia Cell Therapy CDMO Market Size by Country (2027-2032) Table 145. South America, Middle East & Africa Cell Therapy CDMO Market Size by Type (2021-2026) & (US$ Million) Table 146. South America, Middle East & Africa Cell Therapy CDMO Market Size by Type (2027-2032) & (US$ Million) Table 147. South America, Middle East & Africa Cell Therapy CDMO Market Size by Application (2021-2026) & (US$ Million) Table 148. South America, Middle East & Africa Cell Therapy CDMO Market Size by Application (2027-2032) & (US$ Million) Table 149. South America, Middle East & Africa Cell Therapy CDMO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. South America, Middle East & Africa Cell Therapy CDMO Market Size by Country (2021-2026) Table 151. South America, Middle East & Africa Cell Therapy CDMO Market Size by Country (2027-2032) Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Cell Therapy CDMO Product Image Figure 2. Global Cell Therapy CDMO Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Cell Therapy CDMO Market Share by Type: 2025 VS 2032 Figure 4. Autologous Cell Therapy CDMO Image Figure 5. Allogeneic Cell Therapy CDMO Image Figure 6. Viral Vector and Gene Editing CDMO Image Figure 7. Global Cell Therapy CDMO Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Cell Therapy CDMO Market Share by Application: 2025 VS 2032 Figure 9. Commercial Image Figure 10. Academic Research Image Figure 11. Others Image Figure 12. Global Cell Therapy CDMO Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Cell Therapy CDMO Market Size (2021-2032) & (US$ Million) Figure 14. Global Cell Therapy CDMO Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Cell Therapy CDMO Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Cell Therapy CDMO Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Cell Therapy CDMO Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Cell Therapy CDMO Revenue Market Share by Type (2021-2032) Figure 21. Global Cell Therapy CDMO Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Cell Therapy CDMO Revenue Market Share by Application (2021-2032) Figure 23. North America Cell Therapy CDMO Market Size (2021-2032) & (US$ Million) Figure 24. North America Cell Therapy CDMO Market Share by Type (2021-2032) Figure 25. North America Cell Therapy CDMO Market Share by Application (2021-2032) Figure 26. North America Cell Therapy CDMO Market Share by Country (2021-2032) Figure 27. United States Cell Therapy CDMO Market Size (2021-2032) & (US$ Million) Figure 28. Canada Cell Therapy CDMO Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Cell Therapy CDMO Market Size (2021-2032) & (US$ Million) Figure 30. Europe Cell Therapy CDMO Market Size (2021-2032) & (US$ Million) Figure 31. Europe Cell Therapy CDMO Market Share by Type (2021-2032) Figure 32. Europe Cell Therapy CDMO Market Share by Application (2021-2032) Figure 33. Europe Cell Therapy CDMO Market Share by Country (2021-2032) Figure 34. Germany Cell Therapy CDMO Market Size (2021-2032) & (US$ Million) Figure 35. France Cell Therapy CDMO Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Cell Therapy CDMO Market Size (2021-2032) & (US$ Million) Figure 37. Italy Cell Therapy CDMO Market Size (2021-2032) & (US$ Million) Figure 38. Russia Cell Therapy CDMO Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Cell Therapy CDMO Market Size (2021-2032) & (US$ Million) Figure 40. China Cell Therapy CDMO Market Size (2021-2032) & (US$ Million) Figure 41. China Cell Therapy CDMO Market Share by Type (2021-2032) Figure 42. China Cell Therapy CDMO Market Share by Application (2021-2032) Figure 43. Asia Cell Therapy CDMO Market Size (2021-2032) & (US$ Million) Figure 44. Asia Cell Therapy CDMO Market Share by Type (2021-2032) Figure 45. Asia Cell Therapy CDMO Market Share by Application (2021-2032) Figure 46. Asia Cell Therapy CDMO Market Share by Country (2021-2032) Figure 47. Japan Cell Therapy CDMO Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Cell Therapy CDMO Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Cell Therapy CDMO Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Cell Therapy CDMO Market Size (2021-2032) & (US$ Million) Figure 51. India Cell Therapy CDMO Market Size (2021-2032) & (US$ Million) Figure 52. Australia Cell Therapy CDMO Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Cell Therapy CDMO Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Cell Therapy CDMO Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Cell Therapy CDMO Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Cell Therapy CDMO Market Share by Country (2021-2032) Figure 57. Brazil Cell Therapy CDMO Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Cell Therapy CDMO Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Cell Therapy CDMO Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Cell Therapy CDMO Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Cell Therapy CDMO Market Size (2021-2032) & (US$ Million) Figure 62. UAE Cell Therapy CDMO Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Cell Therapy CDMO Market Size (2021-2032) & (US$ Million) Figure 64. Chile Cell Therapy CDMO Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Autologous Cell Therapy CDMO
  • Allogeneic Cell Therapy CDMO
  • Viral Vector and Gene Editing CDMO
Applications
  • Commercial
  • Academic Research
  • Others
Companies covered
  • Catalent
  • Lonza
  • Charles River
  • FUJIFILM Diosynth Biotechnologies
  • Exothera
  • Pharmaron
  • OBiO
  • AGC Biologics
  • Cytiva
  • ThermoGenesis
  • eXmoor Pharma
  • Advanced Therapies
  • Catalent Biologics
  • Patheon Pharma Services
  • Sartorius
  • Genezen
  • The Discovery Labs

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Cell Therapy CDMO Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Autologous Cell Therapy CDMO
  5. 1.2.3 Allogeneic Cell Therapy CDMO
  6. 1.2.4 Viral Vector and Gene Editing CDMO
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Cell Therapy CDMO Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Commercial
  10. 1.3.3 Academic Research
  11. 1.3.4 Others
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Cell Therapy CDMO Growth Trends by Region
  14. 1.5.1 Global Cell Therapy CDMO Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Cell Therapy CDMO Market Size by Region (2021-2026)
  16. 1.5.3 Cell Therapy CDMO Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Cell Therapy CDMO Market Dynamics
  1. 2.1 Cell Therapy CDMO Industry Trends
  2. 2.2 Cell Therapy CDMO Industry Drivers
  3. 2.3 Cell Therapy CDMO Industry Opportunities and Challenges
  4. 2.4 Cell Therapy CDMO Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Cell Therapy CDMO Revenue by Company (2021-2026)
  2. 3.2 Global Cell Therapy CDMO Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Cell Therapy CDMO Key Company Head office and Area Served
  4. 3.4 Global Cell Therapy CDMO Company, Product Type & Application
  5. 3.5 Global Cell Therapy CDMO Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Cell Therapy CDMO Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Cell Therapy CDMO Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Cell Therapy CDMO Tier 1, Tier 2, and Tier 3
4 Cell Therapy CDMO Market by Type
  1. 4.1 Global Cell Therapy CDMO Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Cell Therapy CDMO Market Size by Type (2021-2032)
  3. 4.3 Global Cell Therapy CDMO Market Size Share by Type (2021-2032)
5 Cell Therapy CDMO Market by Application
  1. 5.1 Global Cell Therapy CDMO Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Cell Therapy CDMO Market Size by Application (2021-2032)
  3. 5.3 Global Cell Therapy CDMO Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Catalent
  2. 6.1.1 Catalent Company Information
  3. 6.1.2 Catalent Business Overview
  4. 6.1.3 Catalent Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Catalent Cell Therapy CDMO Product Portfolio
  6. 6.1.5 Catalent Recent Developments
  7. 6.2 Lonza
  8. 6.2.1 Lonza Company Information
  9. 6.2.2 Lonza Business Overview
  10. 6.2.3 Lonza Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Lonza Cell Therapy CDMO Product Portfolio
  12. 6.2.5 Lonza Recent Developments
  13. 6.3 Charles River
  14. 6.3.1 Charles River Company Information
  15. 6.3.2 Charles River Business Overview
  16. 6.3.3 Charles River Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Charles River Cell Therapy CDMO Product Portfolio
  18. 6.3.5 Charles River Recent Developments
  19. 6.4 FUJIFILM Diosynth Biotechnologies
  20. 6.4.1 FUJIFILM Diosynth Biotechnologies Company Information
  21. 6.4.2 FUJIFILM Diosynth Biotechnologies Business Overview
  22. 6.4.3 FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Product Portfolio
  24. 6.4.5 FUJIFILM Diosynth Biotechnologies Recent Developments
  25. 6.5 Exothera
  26. 6.5.1 Exothera Company Information
  27. 6.5.2 Exothera Business Overview
  28. 6.5.3 Exothera Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Exothera Cell Therapy CDMO Product Portfolio
  30. 6.5.5 Exothera Recent Developments
  31. 6.6 Pharmaron
  32. 6.6.1 Pharmaron Company Information
  33. 6.6.2 Pharmaron Business Overview
  34. 6.6.3 Pharmaron Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Pharmaron Cell Therapy CDMO Product Portfolio
  36. 6.6.5 Pharmaron Recent Developments
  37. 6.7 OBiO
  38. 6.7.1 OBiO Company Information
  39. 6.7.2 OBiO Business Overview
  40. 6.7.3 OBiO Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 OBiO Cell Therapy CDMO Product Portfolio
  42. 6.7.5 OBiO Recent Developments
  43. 6.8 AGC Biologics
  44. 6.8.1 AGC Biologics Company Information
  45. 6.8.2 AGC Biologics Business Overview
  46. 6.8.3 AGC Biologics Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 AGC Biologics Cell Therapy CDMO Product Portfolio
  48. 6.8.5 AGC Biologics Recent Developments
  49. 6.9 Cytiva
  50. 6.9.1 Cytiva Company Information
  51. 6.9.2 Cytiva Business Overview
  52. 6.9.3 Cytiva Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Cytiva Cell Therapy CDMO Product Portfolio
  54. 6.9.5 Cytiva Recent Developments
  55. 6.10 ThermoGenesis
  56. 6.10.1 ThermoGenesis Company Information
  57. 6.10.2 ThermoGenesis Business Overview
  58. 6.10.3 ThermoGenesis Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 ThermoGenesis Cell Therapy CDMO Product Portfolio
  60. 6.10.5 ThermoGenesis Recent Developments
  61. 6.11 eXmoor Pharma
  62. 6.11.1 eXmoor Pharma Company Information
  63. 6.11.2 eXmoor Pharma Business Overview
  64. 6.11.3 eXmoor Pharma Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 eXmoor Pharma Cell Therapy CDMO Product Portfolio
  66. 6.11.5 eXmoor Pharma Recent Developments
  67. 6.12 Advanced Therapies
  68. 6.12.1 Advanced Therapies Company Information
  69. 6.12.2 Advanced Therapies Business Overview
  70. 6.12.3 Advanced Therapies Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Advanced Therapies Cell Therapy CDMO Product Portfolio
  72. 6.12.5 Advanced Therapies Recent Developments
  73. 6.13 Catalent Biologics
  74. 6.13.1 Catalent Biologics Company Information
  75. 6.13.2 Catalent Biologics Business Overview
  76. 6.13.3 Catalent Biologics Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Catalent Biologics Cell Therapy CDMO Product Portfolio
  78. 6.13.5 Catalent Biologics Recent Developments
  79. 6.14 Patheon Pharma Services
  80. 6.14.1 Patheon Pharma Services Company Information
  81. 6.14.2 Patheon Pharma Services Business Overview
  82. 6.14.3 Patheon Pharma Services Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Patheon Pharma Services Cell Therapy CDMO Product Portfolio
  84. 6.14.5 Patheon Pharma Services Recent Developments
  85. 6.15 Sartorius
  86. 6.15.1 Sartorius Company Information
  87. 6.15.2 Sartorius Business Overview
  88. 6.15.3 Sartorius Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Sartorius Cell Therapy CDMO Product Portfolio
  90. 6.15.5 Sartorius Recent Developments
  91. 6.16 Genezen
  92. 6.16.1 Genezen Company Information
  93. 6.16.2 Genezen Business Overview
  94. 6.16.3 Genezen Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Genezen Cell Therapy CDMO Product Portfolio
  96. 6.16.5 Genezen Recent Developments
  97. 6.17 The Discovery Labs
  98. 6.17.1 The Discovery Labs Company Information
  99. 6.17.2 The Discovery Labs Business Overview
  100. 6.17.3 The Discovery Labs Cell Therapy CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 The Discovery Labs Cell Therapy CDMO Product Portfolio
  102. 6.17.5 The Discovery Labs Recent Developments
7 North America
  1. 7.1 North America Cell Therapy CDMO Market Size (2021-2032)
  2. 7.2 North America Cell Therapy CDMO Market Size by Type
  3. 7.2.1 North America Cell Therapy CDMO Market Size by Type (2021-2026)
  4. 7.2.2 North America Cell Therapy CDMO Market Size by Type (2027-2032)
  5. 7.2.3 North America Cell Therapy CDMO Market Share by Type (2021-2032)
  6. 7.3 North America Cell Therapy CDMO Market Size by Application
  7. 7.3.1 North America Cell Therapy CDMO Market Size by Application (2021-2026)
  8. 7.3.2 North America Cell Therapy CDMO Market Size by Application (2027-2032)
  9. 7.3.3 North America Cell Therapy CDMO Market Share by Application (2021-2032)
  10. 7.4 North America Cell Therapy CDMO Market Size by Country
  11. 7.4.1 North America Cell Therapy CDMO Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Cell Therapy CDMO Market Size by Country (2021-2026)
  13. 7.4.3 North America Cell Therapy CDMO Market Size by Country (2027-2032)
  14. 7.4.4 North America Cell Therapy CDMO Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Cell Therapy CDMO Market Size (2021-2032)
  2. 8.2 Europe Cell Therapy CDMO Market Size by Type
  3. 8.2.1 Europe Cell Therapy CDMO Market Size by Type (2021-2026)
  4. 8.2.2 Europe Cell Therapy CDMO Market Size by Type (2027-2032)
  5. 8.2.3 Europe Cell Therapy CDMO Market Share by Type (2021-2032)
  6. 8.3 Europe Cell Therapy CDMO Market Size by Application
  7. 8.3.1 Europe Cell Therapy CDMO Market Size by Application (2021-2026)
  8. 8.3.2 Europe Cell Therapy CDMO Market Size by Application (2027-2032)
  9. 8.3.3 Europe Cell Therapy CDMO Market Share by Application (2021-2032)
  10. 8.4 Europe Cell Therapy CDMO Market Size by Country
  11. 8.4.1 Europe Cell Therapy CDMO Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Cell Therapy CDMO Market Size by Country (2021-2026)
  13. 8.4.3 Europe Cell Therapy CDMO Market Size by Country (2027-2032)
  14. 8.4.4 Europe Cell Therapy CDMO Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Cell Therapy CDMO Market Size (2021-2032)
  2. 9.2 China Cell Therapy CDMO Market Size by Type
  3. 9.2.1 China Cell Therapy CDMO Market Size by Type (2021-2026)
  4. 9.2.2 China Cell Therapy CDMO Market Size by Type (2027-2032)
  5. 9.2.3 China Cell Therapy CDMO Market Share by Type (2021-2032)
  6. 9.3 China Cell Therapy CDMO Market Size by Application
  7. 9.3.1 China Cell Therapy CDMO Market Size by Application (2021-2026)
  8. 9.3.2 China Cell Therapy CDMO Market Size by Application (2027-2032)
  9. 9.3.3 China Cell Therapy CDMO Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Cell Therapy CDMO Market Size (2021-2032)
  2. 10.2 Asia Cell Therapy CDMO Market Size by Type
  3. 10.2.1 Asia Cell Therapy CDMO Market Size by Type (2021-2026)
  4. 10.2.2 Asia Cell Therapy CDMO Market Size by Type (2027-2032)
  5. 10.2.3 Asia Cell Therapy CDMO Market Share by Type (2021-2032)
  6. 10.3 Asia Cell Therapy CDMO Market Size by Application
  7. 10.3.1 Asia Cell Therapy CDMO Market Size by Application (2021-2026)
  8. 10.3.2 Asia Cell Therapy CDMO Market Size by Application (2027-2032)
  9. 10.3.3 Asia Cell Therapy CDMO Market Share by Application (2021-2032)
  10. 10.4 Asia Cell Therapy CDMO Market Size by Country
  11. 10.4.1 Asia Cell Therapy CDMO Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Cell Therapy CDMO Market Size by Country (2021-2026)
  13. 10.4.3 Asia Cell Therapy CDMO Market Size by Country (2027-2032)
  14. 10.4.4 Asia Cell Therapy CDMO Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Cell Therapy CDMO Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Cell Therapy CDMO Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Cell Therapy CDMO Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Cell Therapy CDMO Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Cell Therapy CDMO Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Cell Therapy CDMO Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Cell Therapy CDMO Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Cell Therapy CDMO Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Cell Therapy CDMO Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Cell Therapy CDMO Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Cell Therapy CDMO Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Cell Therapy CDMO Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Cell Therapy CDMO Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Cell Therapy CDMO Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst